Psmb6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PSMB6 (Proteasome Subunit Beta 6) encodes the β6 catalytic subunit of the 20S proteasome core particle. This subunit provides the proteasome's caspase-like (or post-acidic) proteolytic activity, cleaving peptides after acidic residues. PSMB6 is essential for proper proteasome function and plays a critical role in protein homeostasis throughout the central nervous system. [1]
The proteasome is a key component of the ubiquitin-proteasome system (UPS), which is responsible for degrading misfolded, oxidized, and regulatory proteins. In neurons, where protein turnover is carefully regulated to maintain synaptic function and prevent aggregation, proteasome activity is particularly crucial. [2]
| Attribute | Value | [3]
|---|---| [4]
| Gene Symbol | PSMB6 | [5]
| Full Name | Proteasome Subunit Beta 6 | [6]
| Chromosomal Location | 17p13.1 | [7]
| NCBI Gene ID | 5699 |
| OMIM | N/A |
| Ensembl ID | ENSG00000104613 |
| UniProt ID | P28074 |
| Protein Length | 204 amino acids |
| Molecular Weight | ~25 kDa |
PSMB6 is a catalytic β-subunit belonging to the Ntn-hydrolase family. The protein contains an N-terminal threonine residue (Thr1) that serves as the active site nucleophile for proteolysis.
The 20S proteasome contains three distinct catalytic subunits with different substrate specificities:
| Subunit | Activity | Cleavage Specificity |
|---|---|---|
| PSMB6 (β6) | Caspase-like (post-acidic) | After acidic residues (D, E) |
| PSMB2 (β2) | Trypsin-like | After basic residues (K, R, H) |
| PSMB5 (β5) | Chymotrypsin-like | After hydrophobic residues (L, I, V, Y, F) |
PSMB6's caspase-like activity is essential for:
In neurons, the proteasome system is critical for:
PSMB6 is ubiquitously expressed throughout the brain with high levels in:
Proteasome activity is significantly reduced in AD brain tissue, contributing to:
Research has shown that PSMB6 expression and activity are altered in AD:
The ubiquitin-proteasome system is central to PD pathogenesis:
While PSMB6 itself is not a direct drug target, understanding its function informs:
The study of Psmb6 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The ubiquitin-proteasome system in Alzheimer's disease pathogenesis. Acta Neuropathol. 2019. ↩︎
Structure of the human 20S proteasome. Trends Biochem Sci. 2019. ↩︎
Proteasome dysfunction in Parkinson's disease. Neurobiol Aging. 2020. ↩︎
Caspase-like activity of the proteasome. J Mol Biol. 2018. ↩︎
Neuronal proteostasis and neurodegenerative disease. Neuron. 2020. ↩︎
Oxidative stress and proteasome function. Free Radic Biol Med. 2019. ↩︎
Therapeutic targeting of the proteasome in neurodegeneration. Nat Rev Neurol. 2021. ↩︎